Ulcerative colitis practice guidelines in adults (update): American College of Gastroenterology, Practice Parameters Committee

被引:466
作者
Kornbluth, A [1 ]
Sachar, DB [1 ]
机构
[1] Mt Sinai Sch Med, Dept Med, Henry D Janowitz Div Gastroenterol, Brooklyn, NY USA
关键词
D O I
10.1111/j.1572-0241.2004.40036.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Guidelines for clinical practice are intended to indicate preferred approaches to medical problems as established by scientifically valid research. Double-blind placebo-controlled studies are preferable, but compassionate use reports and expert review articles are utilized in a thorough review of the literature conducted through Medline with the National Library of Medicine. When only data that will not withstand objective scrutiny are available, a recommendation is identified as a consensus of experts. Guidelines are applicable to all physicians who address the subject without regard to the specialty training or interests and are intended to indicate the preferable but not necessarily the only acceptable approach to a specific problem. Guidelines are intended to be flexible and must be distinguished from standards of care, which are inflexible and rarely violated. Given the wide range of specifics in any health-care problem, the physician must always choose the course best suited to the individual patient and the variables in existence at the moment of decision. Guidelines are developed under the auspices of the American College of Gastroenterology and its Practice Parameters Committee and approved by the Board of Trustees. Each has been extensively reviewed and revised by the Committee, other experts in the field, physicians who will use them, and specialists in the science of decision of analysis. The recommendations of each guideline are therefore considered valid at the time of their production based on the data available. New developments in medical research and practice pertinent to each guideline will be reviewed at a time established and indicated at the publication in order to assure continued validity.
引用
收藏
页码:1371 / 1385
页数:15
相关论文
共 217 条
[1]   Corticosteroids and immunomodulators: Postoperative infectious complication risk in inflammatory bowel disease patients [J].
Aberra, FN ;
Lewis, JD ;
Hass, D ;
Rombeau, JL ;
Osborne, B ;
Lichtenstein, GR .
GASTROENTEROLOGY, 2003, 125 (02) :320-327
[2]   Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis [J].
Adachi, JD ;
Bensen, WG ;
Brown, J ;
Hanley, D ;
Hodsman, A ;
Josse, R ;
Kendler, DL ;
Lentle, B ;
Olszynski, W ;
SteMarie, LG ;
Tenenhouse, A ;
Chines, AA .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (06) :382-387
[3]  
ADLER DJ, 1990, AM J GASTROENTEROL, V85, P717
[4]   AUTO-IMMUNE HEMOLYTIC-ANEMIA IN ULCERATIVE-COLITIS - REPORT OF 3 CASES, REVIEW OF THE LITERATURE, AND EVALUATION OF MODES OF THERAPY [J].
ALTMAN, AR ;
MALTZ, C ;
JANOWITZ, HD .
DIGESTIVE DISEASES AND SCIENCES, 1979, 24 (04) :282-285
[5]  
*AM GASTR ASS, 2001, INT DIS, P30
[6]  
American Gastroenterological Association, 2003, GASTROENTEROLOGY, V124, P791, DOI DOI 10.1053/GAST.2003
[7]  
Andreoli A, 1999, GASTROENTEROLOGY, V116, pG2883
[8]  
[Anonymous], GUT
[9]  
ARNER O, 1971, ACTA MED SCAND, V189, P275
[10]   Family history as a risk factor for colorectal cancer in inflammatory bowel disease [J].
Askling, J ;
Dickman, PW ;
Karlén, P ;
Broström, O ;
Lapidus, A ;
Löfberg, R ;
Ekbom, A .
GASTROENTEROLOGY, 2001, 120 (06) :1356-1362